Novolog Pharm Cash Per Share vs. Profit Margin
| NVLG Stock | 169.90 0.50 0.30% |
For Novolog Pharm profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Novolog Pharm to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Novolog Pharm Up 1966 utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Novolog Pharm's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Novolog Pharm Up 1966 over time as well as its relative position and ranking within its peers.
Novolog |
Novolog Pharm Up Profit Margin vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Novolog Pharm's current stock value. Our valuation model uses many indicators to compare Novolog Pharm value to that of its competitors to determine the firm's financial worth. Novolog Pharm Up 1966 is considered to be number one stock in cash per share category among its peers. It also is considered to be number one stock in profit margin category among its peers fabricating about 0.10 of Profit Margin per Cash Per Share. The ratio of Cash Per Share to Profit Margin for Novolog Pharm Up 1966 is roughly 10.10 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Novolog Pharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Novolog Pharm's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Novolog Profit Margin vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Novolog Pharm |
| = | 0.31 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Novolog Pharm |
| = | 0.03 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Novolog Profit Margin Comparison
Novolog Pharm is currently under evaluation in profit margin category among its peers.
Novolog Pharm Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Novolog Pharm, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Novolog Pharm will eventually generate negative long term returns. The profitability progress is the general direction of Novolog Pharm's change in net profit over the period of time. It can combine multiple indicators of Novolog Pharm, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange.
Novolog Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Novolog Pharm. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Novolog Pharm position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Novolog Pharm's important profitability drivers and their relationship over time.
Use Novolog Pharm in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novolog Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novolog Pharm will appreciate offsetting losses from the drop in the long position's value.Novolog Pharm Pair Trading
Novolog Pharm Up 1966 Pair Trading Analysis
The ability to find closely correlated positions to Novolog Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novolog Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novolog Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novolog Pharm Up 1966 to buy it.
The correlation of Novolog Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novolog Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novolog Pharm Up moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novolog Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Novolog Pharm position
In addition to having Novolog Pharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Business Services Thematic Idea Now
Business Services
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Services Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Novolog Stock
To fully project Novolog Pharm's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Novolog Pharm Up at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Novolog Pharm's income statement, its balance sheet, and the statement of cash flows.